Skip to content

Rafael Holdings, Inc. RFL Acquired Inprocess Researchamp Development Due To Cyclo Merger

Acquired Inprocess Researchamp Development Due To Cyclo Merger at other companies

Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$0
Envoy Medical logo
Envoy MedicalCOCH
$3.64M+32.5%
Digi International logo
Digi InternationalDGII
$300K
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$32M
DTC
Datacentrex, Inc. DTCX
$31.87K-53.4%
Hamilton Lane logo
Hamilton LaneHLNE
$0-100%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept rfl:AcquiredInprocessResearchampDevelopmentDueToCycloMerger.

The official record: Rafael Holdings, Inc.’s 10-K, filed October 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s acquired inprocess researchamp development due to cyclo merger.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s acquired inprocess researchamp development due to cyclo merger?
Rafael Holdings, Inc. (RFL) reported acquired inprocess researchamp development due to cyclo merger of $7.5M in Q2 2025.
What does acquired inprocess researchamp development due to cyclo merger mean?
The fair value of research and development projects acquired through a business combination that have not yet reached technological feasibility. This metric is critical for assessing the value of the acquired pipeline and future innovation potential.